T1	Participants 36 50	statin therapy
T2	Participants 147 178	patients with limited prognosis
T3	Participants 389 426	patients with limited life expectancy
T4	Participants 528 567	patients in the palliative care setting
T6	Participants 680 958	Eligibility included adults with an estimated life expectancy of between 1 month and 1 year, statin therapy for 3 months or more for primary or secondary prevention of cardiovascular disease, recent deterioration in functional status, and no recent active cardiovascular disease
T10	Participants 1616 1653	A total of 381 patients were enrolled
T5	Participants 1753 1864	Mean (SD) age was 74.1 (11.6) years, 22.0% of the participants were cognitively impaired, and 48.8% had cancer.
